pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Avelas Biosciences aims to use its proprietary platform technology of activatable cell-penetrating peptides (ACPPs) for both surgical and therapeutic applications to create better outcomes for cancer patients.
LOCATION
La Jolla, CA, USA
THERAPEUTIC AREAS
Oncology
WEBSITE
https://www.avelasbio.com/
CAREER WEBSITE
https://www.avelasbio.com/careers/
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Sep 26, 2018
Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference
Aug 2, 2018
Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Jun 14, 2018
Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference
Mar 21, 2018
Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference
Jan 4, 2018
Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery
For More Press Releases